These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 33459640)

  • 41. Unexpected abundance of pathological tau in progressive supranuclear palsy white matter.
    Zhukareva V; Joyce S; Schuck T; Van Deerlin V; Hurtig H; Albin R; Gilman S; Chin S; Miller B; Trojanowski JQ; Lee VM
    Ann Neurol; 2006 Sep; 60(3):335-45. PubMed ID: 16823854
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Expression patterns of tau mRNA isoforms correlate with susceptible lesions in progressive supranuclear palsy and corticobasal degeneration.
    Takanashi M; Mori H; Arima K; Mizuno Y; Hattori N
    Brain Res Mol Brain Res; 2002 Aug; 104(2):210-9. PubMed ID: 12225876
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Structure of NFT: Biochemical Approach.
    Hasegawa M
    Adv Exp Med Biol; 2019; 1184():23-34. PubMed ID: 32096025
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Transgenic mouse model of tauopathies with glial pathology and nervous system degeneration.
    Higuchi M; Ishihara T; Zhang B; Hong M; Andreadis A; Trojanowski J; Lee VM
    Neuron; 2002 Aug; 35(3):433-46. PubMed ID: 12165467
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical and pathological study of two patients with progressive supranuclear palsy and Alzheimer's changes. Antigenic determinants that distinguish cortical and subcortical neurofibrillary tangles.
    Cruz-Sanchez FF; Rossi ML; Cardozo A; Deacon P; Tolosa E
    Neurosci Lett; 1992 Feb; 136(1):43-6. PubMed ID: 1321966
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Internalization mechanisms of brain-derived tau oligomers from patients with Alzheimer's disease, progressive supranuclear palsy and dementia with Lewy bodies.
    Puangmalai N; Bhatt N; Montalbano M; Sengupta U; Gaikwad S; Ventura F; McAllen S; Ellsworth A; Garcia S; Kayed R
    Cell Death Dis; 2020 May; 11(5):314. PubMed ID: 32366836
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Specific detection of pathological three-repeat tau after pretreatment with potassium permanganate and oxalic acid in PSP/CBD brains.
    Uchihara T; Nakamura A; Shibuya K; Yagishita S
    Brain Pathol; 2011 Mar; 21(2):180-8. PubMed ID: 20825412
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Morphological and biochemical correlations of abnormal tau filaments in progressive supranuclear palsy.
    Takahashi M; Weidenheim KM; Dickson DW; Ksiezak-Reding H
    J Neuropathol Exp Neurol; 2002 Jan; 61(1):33-45. PubMed ID: 11829342
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Distinct involvement of the cranial and spinal nerves in progressive supranuclear palsy.
    Tanaka H; Martinez-Valbuena I; Forrest SL; Couto B; Reyes NG; Morales-Rivero A; Lee S; Li J; Karakani AM; Tang-Wai DF; Tator C; Khadadadi M; Sadia N; Tartaglia MC; Lang AE; Kovacs GG
    Brain; 2024 Apr; 147(4):1399-1411. PubMed ID: 37972275
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tau exhibits unique seeding properties in globular glial tauopathy.
    Chung DC; Carlomagno Y; Cook CN; Jansen-West K; Daughrity L; Lewis-Tuffin LJ; Castanedes-Casey M; DeTure M; Dickson DW; Petrucelli L
    Acta Neuropathol Commun; 2019 Mar; 7(1):36. PubMed ID: 30845985
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tau Isoform Profile in Essential Tremor Diverges From Other Tauopathies.
    Kim SH; Farrell K; Cosentino S; Vonsattel JG; Faust PL; Cortes EP; Bennet DA; Louis ED; Crary JF
    J Neuropathol Exp Neurol; 2021 Sep; 80(9):835-843. PubMed ID: 34363663
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dysregulated coordination of MAPT exon 2 and exon 10 splicing underlies different tau pathologies in PSP and AD.
    Bowles KR; Pugh DA; Oja LM; Jadow BM; Farrell K; Whitney K; Sharma A; Cherry JD; Raj T; Pereira AC; Crary JF; Goate AM
    Acta Neuropathol; 2022 Feb; 143(2):225-243. PubMed ID: 34874463
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Increase in the relative expression of tau with four microtubule binding repeat regions in frontotemporal lobar degeneration and progressive supranuclear palsy brains.
    Ingelsson M; Ramasamy K; Russ C; Freeman SH; Orne J; Raju S; Matsui T; Growdon JH; Frosch MP; Ghetti B; Brown RH; Irizarry MC; Hyman BT
    Acta Neuropathol; 2007 Nov; 114(5):471-9. PubMed ID: 17721707
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Differential incorporation of tau isoforms in Alzheimer's disease.
    Espinoza M; de Silva R; Dickson DW; Davies P
    J Alzheimers Dis; 2008 May; 14(1):1-16. PubMed ID: 18525123
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Astrocytic tau pathology positively correlates with neurofibrillary tangle density in progressive supranuclear palsy.
    Ito K; Arai K; Yoshiyama Y; Kashiwado K; Sakakibara Y; Hattori T
    Acta Neuropathol; 2008 Jun; 115(6):623-8. PubMed ID: 18427815
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A Machine Learning-Based Approach to Discrimination of Tauopathies Using [
    Endo H; Tagai K; Ono M; Ikoma Y; Oyama A; Matsuoka K; Kokubo N; Hirata K; Sano Y; Oya M; Matsumoto H; Kurose S; Seki C; Shimizu H; Kakita A; Takahata K; Shinotoh H; Shimada H; Tokuda T; Kawamura K; Zhang MR; Oishi K; Mori S; Takado Y; Higuchi M
    Mov Disord; 2022 Nov; 37(11):2236-2246. PubMed ID: 36054492
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lewy bodies in progressive supranuclear palsy represent an independent disease process.
    Uchikado H; DelleDonne A; Ahmed Z; Dickson DW
    J Neuropathol Exp Neurol; 2006 Apr; 65(4):387-95. PubMed ID: 16691119
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cerebellar cortical tau pathology in progressive supranuclear palsy and corticobasal degeneration.
    Piao YS; Hayashi S; Wakabayashi K; Kakita A; Aida I; Yamada M; Takahashi H
    Acta Neuropathol; 2002 May; 103(5):469-74. PubMed ID: 11935262
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Abnormal Tau proteins in progressive supranuclear palsy. Similarities and differences with the neurofibrillary degeneration of the Alzheimer type.
    Flament S; Delacourte A; Verny M; Hauw JJ; Javoy-Agid F
    Acta Neuropathol; 1991; 81(6):591-6. PubMed ID: 1831952
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Silver stains distinguish tau-positive structures in corticobasal degeneration/progressive supranuclear palsy and in Alzheimer's disease--comparison between Gallyas and Campbell-Switzer methods.
    Uchihara T; Shibuya K; Nakamura A; Yagishita S
    Acta Neuropathol; 2005 Mar; 109(3):299-305. PubMed ID: 15619127
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.